Galena Biopharma Announces NeuVax(TM) Poster Presentations at the 34th Annual Cancer Therapy & Research Center (CTRC)-American Association for Cancer Research San Antonio Breast Cancer Symposium

LAKE OSWEGO, Ore., Nov. 18, 2011 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced two presentations at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. The event will be held December 6-10, 2011 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.

MORE ON THIS TOPIC